Clinical Trial Update: CAV Regimen for R/R AML [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating the CAV regimen for relapsed/refractory acute myeloid leukemia is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• CYTARABINE (CYTARABINE)
• Vincristine (vincristine)

Snippet

Sponsor: The First Affiliated Hospital of Soochow University | Conditions: Acute Myeloid Leukemia | Phase 2 | Status: RECRUITING